A Study on The Psychological Determinants of Substance Use among Indian ‎University Students Diagnosed with Borderline Personality Disorder

  • Authors

    • Jamuna Das PhD Research Scholar(clinical psychology, medical science)‎ Department of Psychiatry,‎ IMS & SUM Hospitals, SOA Deemed to be University, Bhubaneswar, Odisha https://orcid.org/0009-0009-1280-3488
    • Jitendriya Biswal Department of Psychiatry, IMS and SUM Hospitals, SOA Deemed to be University, India https://orcid.org/0000-0003-4343-4880
    • Rakesh Mohanty Department of Psychiatry, IMS and SUM Hospitals, SOA Deemed to be University, India
    https://doi.org/10.14419/e9zt3783

    Received date: October 28, 2025

    Accepted date: November 22, 2025

    Published date: December 4, 2025

  • Borderline Personality Disorder; Substance Use; Anxiety; Impulsivity; Emotional Dysregulation

  • Abstract

    Background: Borderline personality disorder (BPD) frequently co-occurs with substance use, yet ‎the psychological mechanisms underlying this relationship remain insufficiently understood. This ‎study examines the association between BPD and substance use, with a focus on impulsivity, ‎emotional dysregulation, anxiety, and depression.‎

    Method: A cross-sectional study was conducted between September 2023 and December 2024 ‎among undergraduate students from multiple institutions within a single university in Eastern ‎Odisha. Substance use was assessed using the Alcohol, Smoking, and Substance Involvement ‎Screening Test (ASSIST, Version 3). Psychological constructs were measured using the Difficulties ‎in Emotion Regulation Scale, Barratt Impulsiveness Scale, and Hamilton Depression and Anxiety ‎Rating Scales (HAM-D, HAM-A).‎

    Results: Of the total participants, 5.8% (N = 115) met criteria for BPD, and 37.3% (N = 43) of ‎these reported substance use. Cannabis (81.4%) and tobacco (60.5%) were the most commonly used ‎substances among individuals with BPD, whereas alcohol, opioids, sedatives, inhalants, and other ‎drugs showed lower prevalence. Psychological symptoms were highly prevalent in the BPD group, ‎including impulsivity (62.6%), emotional dysregulation (67.9%), anxiety (53.1%), and depression ‎‎(34.8%). Substance use demonstrated strong associations with anxiety (χ² = 20.786, OR = 10.307, p ‎‎< 0.001), emotional dysregulation (χ² = 8.196, OR = 4.296, p = 0.004), and impulsivity (χ² = 12.624, ‎OR = 6.576, p < 0.001). In contrast, depression was not significantly associated with substance use ‎‎(p = 0.409). ‎

    Conclusion: Adults with BPD exhibit significantly higher rates of substance use, particularly ‎cannabis and tobacco, compared to their non-BPD counterparts. Psychological factors, especially ‎impulsivity, emotional dysregulation, and anxiety, emerged as strong predictors of substance-use ‎vulnerability, whereas depression did not show a significant association‎.

  • References

    1. Giulio P. Borderline personality disorder: Definition, differential diagnosis, clinical contexts, and therapeutic approaches. Annals of Psychiatry and Treatment. Vol . 4,n-1 pp: 043-056. , 2020. https://doi.org/10.17352/apt.000020.
    2. Miller CE, Townsend ML, Grenyer BFS. Understanding chronic feelings of emptiness in borderline personality disorder: a qualitative study. Bor-derline Personality Disorder and Emotion Dysregulation. Vol.. 8, n. 1,pp. 1–9, 2021, https://doi.org/10.1186/s40479-021-00164-8.
    3. Kulacaoglu, Filiz, and Samet Kose. “Borderline Personality Disorder (BPD): In the Midst of Vulnerability, Chaos, and Awe.” Brain Sciences.vol.8, no.11, pp. 201.2018, https://doi.org/10.3390/brainsci8110201.
    4. Jia N, Sakulsriprasert C, Wongpakaran N, Suradom C, O’Donnell R. “Borderline Personality Disorder Symptoms and Its Clinical Correlates among Chinese University Students: A Cross-Sectional Study.” Healthcare (Basel, Switzerland) vol. 10,n-9 pp.1751. 2022, https://doi.org/10.3390/healthcare10091751.
    5. Parmar A, Kaloiya G. Comorbidity of Personality Disorder among Substance Use Disorder Patients: A Narrative Review.Indian Journal of Psycho-logical Medicine Vol. 40, no .6, pp. 517-527. 2018, https://doi.org/10.4103/IJPSYM.IJPSYM_164_18.
    6. Trull TJ, Freeman LK, Vebares TJ, Choate AM, Helle AC, Wycoff AM. “Borderline personality disorder and substance use disorders: an updated review.” Borderline personality disorder and emotion dysregulation, vol. 5,no.1, pp.15. 2018, https://doi.org/10.1186/s40479-018-0093-9.
    7. Köck, Patrick and Walter, Marc , Personality disorder and substance use disorder – An update. Mental Health & Prevention, vol. 12, p. 82–89,2018. https://doi.org/10.1016/j.mhp.2018.10.003.
    8. Kienast, Thorsten, Stoffers, Jutta, Bermpohl, Felix and Lieb, Klaus . Borderline Personality Disorder and Comorbid Addiction: Epidemiology and Treatment. Deutsches Ärzteblatt International, vol.111,no.16, p. 280,2014, https://doi.org/10.3238/arztebl.2014.0280.
    9. Stellern, J., Xiao, K. B., Grennell, E., Sanches, M., Gowin, J. L., & Sloan, M. E. (2023). Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction (Abingdon, England), vol. 118,no.1, pp. 30-47. 2023, https://doi.org/10.1111/add.16001.
    10. Carpenter, Ryan W, and Timothy J Trull. “Components of emotion dysregulation in borderline personality disorder: a review.” Current psychiatry reports. vol. 15,no.1 pp. 335.2013, https://doi.org/10.1007/s11920-012-0335-2.
    11. Komarnicki, J., Tobiaszewska, M., Dębowska, W., Dębowska, M., & Szulc, A. “Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?” Frontiers in Psychiatry, vol. 15, pp.1398859. 2024, https://doi.org/10.3389/fpsyt.2024.1398859.
    12. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J“A screening measure for BPD: the McLean Screening In-strument for Borderline Personality Disorder (MSI-BPD).” Journal of Personality Disorders, Vol. 17, No.6, pp.568-73.2003, https://doi.org/10.1521/pedi.17.6.568.25355.
    13. Humeniuk, R., Ali, R., Babor, T., Souza-Formigoni, M. L., de Lacerda, R. B., Ling, W., McRee, B., Newcombe, D., Pal, H., Poznyak, V., Simon, S., & Vendetti, J). A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction (Abingdon, England), 107 no.5, pp.957–966. 2012, https://doi.org/10.1111/j.1360-0443.2011.03740.x.
    14. Humeniuk, Rachel, Henry-Edwards, S., Ali, Robert, Poznyak, Vladimir, Monteiro, Maristela G. et al. (‎2010)‎. The Alcohol, Smoking and Substance Involvement Screening Test (‎ASSIST)‎: manual for use in primary care. World Health Organization. pp.68, URL: https://iris.who.int/handle/10665/44320.
    15. HAMILTON, M. “A rating scale for depression.” Journal of Neurology, Neurosurgery, and Psychiatry Vol. 23,no. 1 pp. 56-62.1960, https://doi.org/10.1136/jnnp.23.1.56.
    16. Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, Vol . 26, no. 1, pp 41-54. https://doi.org/10.1023/B:JOBA.0000007455.08539.94.
    17. Hallion, L. S., Steinman, S. A., Tolin, D. F., & Diefenbach, G. J. “Psychometric Properties of the Difficulties in Emotion Regulation Scale (DERS) and Its Short Forms in Adults with Emotional Disorders.” Frontiers in Psychology vol. 9,no.1, pp. 539,2018, https://doi.org/10.3389/fpsyg.2018.00539.
    18. BARRATT E. S. (1965). FACTOR ANALYSIS OF SOME PSYCHOMETRIC MEASURES OF IMPULSIVENESS AND ANXIETY. Psycho-logical Reports, Vol. 16, no. 2, pp.547-54. 1965, https://doi.org/10.2466/pr0.1965.16.2.547.
    19. Thompson, Euan. “Hamilton Rating Scale for Anxiety (HAM-A).” Occupational medicine (Oxford, England) vol. 65, no .7, pp. 601.2015, https://doi.org/10.1093/occmed/kqv054.
    20. Scalzo F, Hulbert CA, Betts JK, Cotton SM, Chanen AM. “Predictors of substance use in youth with borderline personality disorder.” Personality disorders vol. 9,no.4 pp. 390-396.2018 https://doi.org/10.1037/per0000257.
    21. Bozzatello P, Bellino S, Bosia M, Rocca P. “Early Detection and Outcome in Borderline Personality Disorder.” Frontiers in Psychiatry, vol. 10, no.1, pp 710. 2019, https://doi.org/10.3389/fpsyt.2019.00710.
    22. Bozzatello, P., Blua, C., Brandellero, D., Baldassarri, L., Brasso, C., Rocca, P., & Bellino, S. Gender differences in borderline personality disorder: a narrative review.” Frontiers in Psychiatry. vol. 15, PP.1320546. 2024, https://doi.org/10.3389/fpsyt.2024.1320546.
    23. Distel, M. A., Trull, T. J., de Moor, M. M., Vink, J. M., Geels, L. M., van Beek, J. H., Bartels, M., Willemsen, G., Thiery, E., Derom, C. A., Neale, M. C., & Boomsma, D. I.“Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption.Journal of Personality Disorders, vol. 26, No.6, pp.867-79. 2012, https://doi.org/10.1521/pedi.2012.26.6.867.
    24. Bolshakova M, Bluthenthal R, Sussman S. “Opioid use and misuse: health impact, prevalence, correlates and interventions.” Psychology & health vol. 34,no.9, pp 1105-1139. 2019, https://doi.org/10.1080/08870446.2019.1622013.
    25. Garke, M. Å., Isacsson, N. H., Sörman, K., Bjureberg, J., Hellner, C., Gratz, K. L., Berghoff, C. R., Sinha, R., Tull, M. T., & Jayaram-Lindström, N. “Emotion dysregulation across levels of substance use.” Psychiatry research vol. 296,pp 113662. 2021, https://doi.org/10.1016/j.psychres.2020.113662.
    26. Doran, Neal, and Lyric Tully. “Impulsivity and tobacco product use over time.” Addictive behaviors vol. 85, pp.153-157. 2018, https://doi.org/10.1016/j.addbeh.2018.06.007.
    27. Kenézlői, E., Balogh, L., Somogyi, S., Lévay, E. E., Halmai, Z., Nemoda, Z., Unoka, Z. S., & Réthelyi, J. M. “Emotion dysregulation and impul-sivity as overlapping symptoms in adult Attention-Deficit/Hyperactivity Disorder and Borderline Personality Disorder: severity profiles and associ-ations with childhood traumatization and personality functioning.” Annals of general psychiatry vol. 24,no.1 pp.3. 2025, https://doi.org/10.1186/s12991-024-00540-y.
    28. Kumar PPC, Antony S, Ammapattian T, Kishor M, Sadashiv M. Substance use prevalence and associated factors among Indian college students: A narrative review. Archives of Mental Health vol. 25,no. 1, pp. 77-84, 2024. https://doi.org/10.4103/amh.amh_58_23.
    29. Leichsenring, F., Fonagy, P., Heim, N., Kernberg, O. F., Leweke, F., Luyten, P., Salzer, S., Spitzer, C., & Steinert, C.“Borderline personality disor-der: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies.” World psychiatry: official jour-nal of the World Psychiatric Association (WPA) vol. 23,no.1 pp.4-25. 2024, https://doi.org/10.1002/wps.21156.
    30. Stephen P. Whiteside, Donald R. Lynam.The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity, Personality and Individual Differences, vol.30, no. 4,pp.669-689,2001, https://doi.org/10.1016/S0191-8869(00)00064-7.
    31. Fossati A, Gratz KL, Maffei C, Borroni S. “Impulsivity dimensions, emotion dysregulation, and borderline personality disorder features among Italian nonclinical adolescents.” Borderline personality disorder and emotion dysregulation, vol. 1, pp.5. 2014, https://doi.org/10.1186/2051-6673-1-5.
    32. McGonigal PT, Dixon-Gordon KL. Anger and Emotion Regulation Associated with Borderline and Antisocial Personality Features Within a Cor-rectional Sample. Journal of Correctional Health Care. vol. 26 no.3 ,pp.215-226. 2020 , https://doi.org/10.1177/1078345820937775.
    33. Selby, Edward A, and Thomas E Joiner Jr. “Emotional cascades as prospective predictors of dysregulated behaviors in borderline personality disor-der.” Personality disorders vol. 4,no.2, pp.168-74. 2013, https://doi.org/10.1037/a0029933.
    34. Scheiderer, E. M., Wang, T., Tomko, R. L., Wood, P. K., & Trull, T. J. “Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder.” Clinical psychological science: a journal of the Association for Psychological Science, vol. 4,no.1, pp.67-81. 2016, https://doi.org/10.1177/2167702615573214.
    35. Tong, P., Bo, P., Shi, Y., Dong, L., Sun, T., Gao, X., & Yang, Y. Clinical traits of patients with major depressive disorder with comorbid borderline personality disorder based on propensity score matching.” Depression and anxiety vol. 38,no.1,pp. 100-106.2021, https://doi.org/10.1002/da.23122.
    36. Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. A., Pulay, A. J., Pickering, R. P., & Ruan, W. J.“Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epi-demiologic Survey on Alcohol and Related Conditions.” The Journal of Clinical Psychiatry, vol. 69, no.4 (2008): 533-45. https://doi.org/10.4088/JCP.v69n0404.
    37. Volkow, Nora D, and Carlos Blanco. “Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical as-pects, treatment and prevention.” World Psychiatry. Official journal of the World Psychiatric Association (WPA) . vol. 22, no.2 ,pp. 203-229. 2023, https://doi.org/10.1002/wps.21073.
    38. Kozak K, Lucatch AM, Lowe DJE, Balodis IM, MacKillop J, George TP.“The neurobiology of impulsivity and substance use disorders: implica-tions for treatment.” Annals of the New York Academy of Sciences vol. 1451,no.1,pp.71-91.2019, https://doi.org/10.1111/nyas.13977.

  • Downloads

  • How to Cite

    Das, J., Biswal, J., & Mohanty, R. (2025). A Study on The Psychological Determinants of Substance Use among Indian ‎University Students Diagnosed with Borderline Personality Disorder. International Journal of Basic and Applied Sciences, 14(8), 1-8. https://doi.org/10.14419/e9zt3783